Your shopping cart is currently empty

(+)-Afzelechin (Afzelechin) is isolated from Eysenhardtia subcoriacea. It is an α-glucosidase activity inhibitor, offering neuroprotective effects against glutamate-induced neurotoxicity in HT22 cells and improving reduced glutathione levels in rat pancreas homogenates.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | $458 | Inquiry | Inquiry | |
| 5 mg | $1,018 | Inquiry | Inquiry |
| Description | (+)-Afzelechin (Afzelechin) is isolated from Eysenhardtia subcoriacea. It is an α-glucosidase activity inhibitor, offering neuroprotective effects against glutamate-induced neurotoxicity in HT22 cells and improving reduced glutathione levels in rat pancreas homogenates. |
| Targets&IC50 | α-glucosidase:0.13 mM(ID50) |
| In vitro | Treatment of human umbilical vein endothelial cells (HUVECs) with (+)-Afzelechin (20 μM, 6h) effectively inhibited the production of iNOS and prevented LPS-induced NO synthesis. (+)-AfzelechinC (2-20 μM, 6h) demonstrated its anti-inflammatory ability by down-regulating IL-1β expression in LPS-treated HUVEC. [1] (+)-Afzelechin improves the efficacy of sepsis induced ALI by modulating TLR4/NF-κB, PI3K/Akt, Hippo, and Rho signaling pathways to reduce inflammation. [2] |
| In vivo | (+)-Afzelechin (0.04-0.4 mg/kg, intravenously), results showed significantly reduced iNOS expression in mice with LPS-induced lung injury models, indicating the anti-inflammatory activity of (+)-Afzelechin in vivo. [1] |
| Synonyms | Afzelechin |
| Molecular Weight | 274.27 |
| Formula | C15H14O5 |
| Cas No. | 2545-00-8 |
| Smiles | OC1=C2C(O[C@@H]([C@@H](O)C2)C3=CC=C(O)C=C3)=CC(O)=C1 |
| Relative Density. | 1.492 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (291.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween-80+45% Saline: 3.3 mg/mL (12.03 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.